# Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

> **NCT00364871** · PHASE2 · COMPLETED · sponsor: **Orexigen Therapeutics, Inc** · enrollment: 410 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** naltrexone and bupropion SR

## Key facts

- **NCT ID:** NCT00364871
- **Lead sponsor:** Orexigen Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364871, "Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00364871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*